Cite
HARVARD Citation
Grinsztejn, B. et al. (2019). Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study. Lancet. 6 (9), pp. e588-e600. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Grinsztejn, B. et al. (2019). Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study. Lancet. 6 (9), pp. e588-e600. [Online].